No profile data available.
Waldencast plc (WALD) is an essential consumer products company in the dermatological treatment items industry, based in London, United Kingdom, with about 367 full-time employees.
It reported revenue of $272.07 million for fiscal year 2025, down 0.7% from fiscal year 2024, and net income of -$229.75 million. Its largest business segment, Obagi, brought in 59% of segment revenue in fiscal year 2025; United States was the largest region with 76%. Its market capitalization was $111.87 million as of October 2, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 2, 2026.
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup.
Waldencast reported $272.07 million in revenue for fiscal year 2025, down 0.7% from $273.87 million in fiscal year 2024.
Obagi, with $161.63 million or 59% of segment revenue in fiscal year 2025. Next: Milk Makeup (41%).
United States: 76% of revenue by region in fiscal year 2025, followed by Rest of The World (21%).
$111.87 million as of October 2, 2026.
Listed companies of a similar size in the same industry (dermatological treatment items) include Edgewell Personal Care Company (EPC), Solesence, Inc. (SLSN), Pacific Software, Inc. (PFSF), CCA Industries, Inc. (CAWW).